Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Median Effective Dose of Remimazolam for Sedation in Elderly Patients Undergoing Lower Limb Surgery Under Spinal Anesthesia

NCT05468996 is registered in ClinicalTrials.gov with Asan Medical Center as lead sponsor.

NCT NCT05468996
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05468996 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Median Effective Dose of Remimazolam for Sedation in Elderly Patients Undergoing Lower Limb Surgery Under Spinal Anesthesia
Lead sponsor
Asan Medical Center
Phase
Phase 4
Overall status
Completed
Start date
May 10, 2022
Completion date
October 28, 2022
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

sedative